Who
Vijay K. Iyengar
Director
Company insider
Files Form 4 as: Director, Whitehawk Therapeutics; EVP, Gmapps, Incyte.
In numbers
- Trades disclosed
- 101
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $8.2M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 9 May 2016
- Last trade
- 9 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 11 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,080 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,080 at $0.00 | filing |
| 16 Jul 2025filed 17 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $67K983 at $68.36 | filing |
| 15 Jul 2025filed 16 Jul 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —16,077 at $0.00 | filing |
| 15 Jul 2025filed 16 Jul 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —14,472 at $0.00 | filing |
| 15 Jul 2025filed 16 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $82K1,177 at $69.86 | filing |
| 15 Jul 2025filed 16 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $57K836 at $68.25 | filing |
| 15 Jul 2025filed 16 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —6,430 at $0.00 | filing |
| 14 Jul 2025filed 16 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $42K595 at $69.98 | filing |
| 3 Jul 2025filed 7 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $183K2,682 at $68.16 | filing |
| 3 Jul 2025filed 7 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $404K5,935 at $68.15 | filing |
| 2 Jul 2025filed 7 Jul 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code F | $464K6,809 at $68.17 | filing |
| 1 Apr 2025filed 3 Apr 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —11,159 at $0.00 | filing |
| 1 Apr 2025filed 3 Apr 2025 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —10,982 at $0.00 | filing |
| 17 Jan 2025filed 22 Jan 2025 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —14,772 at $0.00 | filing |
| 29 Nov 2024filed 3 Dec 2024 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $27K360 at $75.60 | filing |
| 29 Nov 2024filed 3 Dec 2024 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $428K5,683 at $75.37 | filing |
| 25 Jul 2024filed 29 Jul 2024 | INCY IncyteLife-science tools | SEC FORM 4 Sold | $1.1M15,571 at $70.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | INCY Incyteoption or derivative · Life-science tools | SEC FORM 4 Code A | —16,284 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | INCY IncyteLife-science tools | SEC FORM 4 Code A | —7,278 at $0.00 | filing |
News
Comparing Madrigal Pharmaceuticals (NASDAQ:MDGL) and Incyte (NASDAQ:INCY)INCY · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Vijay K. Iyengar; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.